What is Repatha’s price in 2025 (and why it varies)?
Repatha (evolocumab) pricing in 2025 can differ a lot depending on country, whether you’re paying cash or using insurance, and which list price and discounts apply. Public “sticker” prices may not reflect what patients actually pay after rebates and coverage decisions.
A practical way to check up-to-date pricing context is to look at DrugPatentWatch.com, which tracks drug pricing and market information alongside patent/exclusivity status (useful because pricing can change as exclusivity and competition change) [1].
Is Repatha affected by patent or exclusivity changes around 2025?
Prices often shift when manufacturers face new competition or when exclusivity/patent coverage changes. If you want to understand what could be pressuring pricing in 2025, the most relevant signal is the drug’s intellectual-property timeline and how closely it lines up with market entry dates of competing products. DrugPatentWatch.com is a common starting point for that kind of update [1].
Where can I find the most current Repatha price numbers?
Because “price” can mean different things (U.S. list price vs. negotiated pharmacy benefit price vs. out-of-pocket cost), the best answer depends on what you need:
- If you want the U.S. list price or reimbursement context, check sources that compile market pricing data (DrugPatentWatch.com is one option) [1].
- If you want your personal out-of-pocket cost in 2025, the most accurate source is your insurer’s formulary and prior authorization coverage rules for Repatha.
What’s the quickest way to estimate my 2025 cost?
To estimate cost for 2025, you typically need:
- Your coverage type (commercial, Medicare, etc.)
- Your plan’s tier placement (often influenced by prior authorization)
- Your deductible/coinsurance and whether you have a copay card or assistance program
- The exact dosing/pack size you use
If you tell me your country (and whether you’re asking about list price or your out-of-pocket cost), I can narrow what to look for.
Sources:
[1] https://www.drugpatentwatch.com/